Alerts will be sent to your verified email
Verify EmailBAJAJHCARE
Bajaj Healthcare
|
Themis Medicare
|
Hester Biosciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
1.2 % | 3.26 % | 1.91 % |
Financials
|
|||
5 yr Average ROE
|
9.93 % | 15.48 % | 10.99 % |
5yr average Equity Multiplier
|
2.26 | 1.56 | 2.14 |
5yr Average Asset Turnover Ratio
|
0.95 | 0.71 | 0.46 |
5yr Avg Net Profit Margin
|
3.65 % | 13.75 % | 11.57 % |
Price to Book
|
2.87 | 2.96 | 5.44 |
P/E
|
28.45 | 0.0 | 45.43 |
5yr Avg Cash Conversion Cycle
|
155.57 Days | 62.99 Days | 60.38 Days |
Inventory Days
|
79.52 Days | 69.58 Days | 100.79 Days |
Days Receivable
|
145.27 Days | 159.79 Days | 89.02 Days |
Days Payable
|
94.44 Days | 137.27 Days | 127.62 Days |
5yr Average Interest Coverage Ratio
|
6.35 | 7.27 | 6.96 |
5yr Avg ROCE
|
24.2 % | 17.31 % | 11.14 % |
5yr Avg Operating Profit Margin
|
16.67 % | 18.07 % | 22.71 % |
5 yr average Debt to Equity
|
0.86 | 0.28 | 0.75 |
5yr CAGR Net Profit
|
-13.82 % | -3.53 % | -4.4 % |
5yr Average Return on Assets
|
5.32 % | 9.9 % | 5.28 % |
Shareholdings
|
|||
Promoter Holding
|
59.19 % | 67.15 % | 53.73 % |
Share Pledged by Promoters
|
0.0 | 2.43 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-8.11 % | -0.03 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
1.66 % | 0.0 | -0.03 % |
Bajaj Healthcare
|
Themis Medicare
|
Hester Biosciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|